Investors

SEC Filings

SEC Filings

Filing date	Form	Description	View
April 8, 2011	D		0001517022-11-000001.pdf 0001517022-11-000001.rtf 0001517022-11-000001.xls View HTML
April 21, 2011	D/A		0001517022-11-000002.pdf 0001517022-11-000002.rtf 0001517022-11-000002.xls View HTML
December 20, 2013	DRS	Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy	0000950123-13-010530.pdf 0000950123-13-010530.rtf 0000950123-13-010530.xls View HTML
January 16, 2014	UPLOAD	UPLOAD	0000000000-14-002536.pdf View HTML
January 27, 2014	DRS/A	mendment to a previously filed DRS	0000950123-14-000635.pdf 0000950123-14-000635.rtf 0000950123-14-000635.xls View HTML
February 14, 2014	S-1	Registration statement for face-amount certificate companies	0001193125-14-055104.pdf 0001193125-14-055104.rtf 0001193125-14-055104.xls View HTML
February 24, 2014	CORRESP	CORRESP	0001193125-14-065132.pdf 0001193125-14-065132.rtf 0001193125-14-065132.xls View HTML
March 3, 2014	UPLOAD	UPLOAD	0000000000-14-010538.pdf View HTML
March 4, 2014	S-1/A	Amended Registration statement for face-amount certificate companies	0001193125-14-081000.pdf 0001193125-14-081000.rtf 0001193125-14-081000.xls View HTML
March 4, 2014	CORRESP	CORRESP	0001193125-14-081274.pdf 0001193125-14-081274.rtf 0001193125-14-081274.xls View HTML

Data provided by Kaleidoscope.

Print Page

Email Page

Contact IR

Email Alerts

Tear Sheet

Akebia Therapeutics, Inc.
245 First Street, Suite 1400
Cambridge, MA 02142

Driving Directions

+1 617.871.2098 phone
+1 617.871.2099 fax